Basic Info
  • Grade: pharmaceutical grade

    Factory Location: china

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Packaging Information: 1kg/bag

  • Sample Provided: no

    Payment Terms: Bank transfer

    Malignant tumors are common diseases that seriously threaten human life. Among them, about 70%~80% of tumor patients need radiation therapy. Radiosensitizers have received a lot of attention from radiotherapy because they can improve the sensitivity of tumor cells to radiation. 2-Nitroimidazole is an important intermediate of a variety of tumor radiation therapy sensitizers, such as misoninitro Chemicalbook (Misonidazole), pimonidazole (pimonidazole), etanidazole (etanidazole) and so on. 2-Nitroimidazole cannot be prepared by the direct nitrification reaction of imidazole, and direct nitrification of imidazole will give 4(5)-nitroimidazole, but not 2-nitroimidazole.
Send your message to this supplier
  • From:
  • To:
    Chongqing Xingcan Pharmaceutical Technology Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service